{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:33:21Z","timestamp":1789227201163,"version":"build-2803163510"},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Information about follow\u2010up care in blood cancer survivors is limited. The questionnaire\u2010based \u201cAftercare in Blood Cancer Survivors\u201d (ABC) study aimed to identify patterns of follow\u2010up care in Germany and compare different types of follow\u2010up institutions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study's 18\u2010month prospective part compared the follow\u2010up institutions identified in the preceding retrospective part (academic oncologists, community oncologists, primary care physicians). The questionnaires were completed by the follow\u2010up physicians.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1070 physicians named by 1479 blood\u2010cancer survivors, 478 (44.7%) consented to participate. For provision of care, most oncologists relied on published guidelines, while most primary care physicians depended on information from other physicians. Survivors with a history of allogeneic transplantation or indolent lymphoma were mainly seen by academic oncologists, whereas survivors with monoclonal gammopathy, multiple myeloma, or myeloproliferative disorders were often seen by community oncologists, and survivors with a history of aggressive lymphoma or acute leukemia by primary care physicians. Detection of relapse and secondary diseases was consistently viewed as the most important follow\u2010up goal. Follow\u2010up visits were most extensively documented by academic oncologists (574 of 1045 survivors cared for, 54.9%), followed by community oncologists (90\/231, 39.0%) and primary care physicians (51\/203, 25.1%). Relapse and secondary disease detection rates and the patients' quality of life were similar at the three institutions. Laboratory tests were most often ordered by academic oncologists, and imaging by primary care physicians. Psychosocial issues and preventive care were more often addressed by primary care physicians than by oncologists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients at high risk of relapse or late complications were preferentially treated by academic oncologists, while patients in stable condition requiring continuous monitoring were also seen by community oncologists, and patients with curable diseases in long\u2010term remission by primary care physicians. For the latter, transfer of follow\u2010up care from oncologists to well\u2010informed primary care providers appears feasible.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cam4.7095","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T07:15:10Z","timestamp":1711696510000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patterns of follow\u2010up care in adult blood cancer survivors\u2014Prospective evaluation of health\u2010related outcomes, resource use, and quality of life"],"prefix":"10.1002","volume":"13","author":[{"given":"Hildegard","family":"Lax","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Medizinische Informatik, Biometrie und Epidemiologie Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Baum","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr H\u00e4matologie Universit\u00e4tsklinikum Essen, Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Medizinische Informatik, Biometrie und Epidemiologie Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Merkel\u2010Jens","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Medizinische Informatik, Biometrie und Epidemiologie Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich W.","family":"Beelen","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Knochenmarktransplantation Universit\u00e4tsklinikum Essen, Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl\u2010Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Medizinische Informatik, Biometrie und Epidemiologie Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-9472","authenticated-orcid":false,"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr H\u00e4matologie Universit\u00e4tsklinikum Essen, Universit\u00e4t Duisburg\u2010Essen  Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12428"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30386-2"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00306-3"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.17226\/11468"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.0474"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055460"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.450"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0729"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-019-00803-8"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_2_11_14_1","volume-title":"Williams Hematology, 9th Edition, Pp 315\u2013352","author":"Izar B","year":"2016"},{"key":"e_1_2_11_15_1","volume-title":"Williams Hematology, 9th Edition, Pp 353\u2013382","author":"Rezvani AR","year":"2016"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3448"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.07.003"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8427"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2443"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq697"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-018-0528-y"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15081007"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-182592"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1274-4"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1188\/15.ONF.E91-E101"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12640"},{"key":"e_1_2_11_27_1","unstructured":"Onkopedia Leitlinien (established in 2010).Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie (DGHO; German Society of Haematology and Medical Oncology).2023https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines"},{"key":"e_1_2_11_28_1","unstructured":"AWMF Leitlinien (established in 1995).Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF; Association of the Scientific Medical Societies in Germany).2023https:\/\/register.awmf.org\/de\/leitlinien\/aktuelle\u2010leitlinien"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.5"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04889-7"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23112"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5866"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.05.011"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-005-5529-z"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(00)00258-0"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24590"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.3232"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1808-4"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmt088"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2524.2012.01075.x"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2021.0519"},{"key":"e_1_2_11_43_1","first-page":"663","article-title":"Evidence\u2010based follow\u2010up for adults with cancer","volume":"116","author":"D\u00fchrsen U","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-016-0328-z"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab049"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00421"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.7095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T09:16:17Z","timestamp":1716282977000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.7095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1002\/cam4.7095"],"URL":"https:\/\/doi.org\/10.1002\/cam4.7095","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"2023-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e7095"}}